All In Biotech

Free tool

FAERS Monitor: Diprolene

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018741 or its brand name (Diprolene, Betamethasone Dipropionate). Reports on generic versions are filed under their own applications.

Reports

6,488

Serious

4,390

68% of reports

Hospitalization

1,999

Death reported

547

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,469
  • off label use666
  • macular degeneration533
  • nausea527
  • psoriasis508
  • pruritus474
  • pain472
  • condition aggravated426
  • fatigue410
  • pain in extremity409
  • rash404
  • headache402
  • dyspnoea360
  • product use in unapproved indication350
  • diarrhoea349

Reports by year received

View as table
YearReports
200423
200542
200634
200738
200827
200938
201026
201152
201272
201354
201467
2015122
2016201
2017230
2018287
2019389
2020471
2021779
2022786
2023791
2024638
2025747
2026574

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,671 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
macular degenerationSignal533151.4139.375,968
psoriasisSignal50812.711.65,454
product use in unapproved indicationSignal3504.64.1987
condition aggravatedSignal4264.54.11,191
pain in extremitySignal4094.54.11,126
pruritusSignal4744.03.71,083
drug ineffectiveSignal1,4693.63.52,960
rashSignal4043.02.7550
painSignal4722.52.3432
off label useSignal6662.52.3604
nauseaSignal5272.22.0339
headacheSignal4022.11.9231
dyspnoeaSignal3602.11.9201
diarrhoea3491.81.6116
fatigue4101.71.6124

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.